Robyn Sayer

Genomic signatures to guide the use of chemotherapeutics

Anil Potti, Holly K. Dressman, Andrea Bild et al. · Nature Medicine · 2006 · 593 citations

Genomic Signatures, Biomolecular Tool, Tumor Heterogeneity +6

An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer

Holly K. Dressman, Andrew Berchuck, Gina Chan et al. · Journal of Clinical Oncology · 2007 · 280 citations · Full text

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer

Robyn Sayer, Johnathan M. Lancaster, Jennifer Pittman et al. · Gynecologic Oncology · 2004 · 91 citations

Medicine, Pathology, Gynecology +8

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

Laura J. Havrilesky, Angeles A. Alvarez, Robyn Sayer et al. · Gynecologic Oncology · 2002 · 74 citations

Peritoneal Cancer, Recurrent Ovarian, Medicine +8

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis

Johnathan M. Lancaster, Holly K. Dressman, Jennifer Clarke et al. · International Journal of Gynecological Cancer · 2006 · 67 citations